Current portfolio

Merus

Innovative full-length bispecific and trispecific antibody therapeutics for oncology.

  • Sector
    Healthcare
  • Country
    Netherlands
  • Fund
    LSP 4
  • Entry
    2010
  • Web
Merus
0
EQT logo